Dermatology
Anaptys reports positive results for its rare skin disease drug and seeks a partner for commercialization
Anika Sharma
AnaptysBio has unveiled promising phase 3 data for its rare skin disease drug candidate, indicating a potential challenge to Boehringer ...
Skyrizi Beats Placebo in Psoriasis Phase 4 Study
SG Tylor
Source – Abbvie On July 26, 2023 AbbVie announced the publication of results from the Phase IV IMMpulse study in ...
Almirall plans to expand its pipeline with €200 million in capital
SG Tylor
Source – Almirall Almirall has completed a €200 million share capital issue, some of which will be used to finalize ...
